High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer.

Cited by papers we hold 7

• Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy · 2022
  No notice
• Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment · 2021
  No notice
• Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies · 2020
  No notice
• Myeloid Cell-Derived Arginase in Cancer Immune Response · 2020
  No notice
• Neutrophil Heterogeneity in Cancer: From Biology to Therapies · 2019
  No notice
• The Role of Tumor-Associated Neutrophils in Colorectal Cancer · 2019
  No notice
• Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.